Immune imbalance after chemotherapy for breast cancer
Conditions
Interventions
Cinese medicine group:Jianpi-Bushen Sanjie recipe
Control group:Regular anti-tumor treatment
Sponsors
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Eligibility
Sex/Gender
Female
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Women with stage I-IIIA breast cancer who meet the above diagnostic criteria of Western medicine and Chinese medicine and are confirmed by clinical and cytology or pathology; Immune imbalance existed in the baseline period; Aged 18-70 years; 2. After radical surgery, the observation period was less than 6 months from the end of radiotherapy and chemotherapy, and no tumor recurrence or metastasis was detected; 3. No history of other malignant tumors, no other diseases that damage or affect immune function; 4. No immunotherapy drugs were used; Did not receive immunotherapy; 5. General KPS (Karnofsky) score >=60 points; 6. No anemia or hypoproteinemia; 7. The required observation content is recorded completely; 8. Be able to understand the purpose and requirements of the study, and voluntarily sign the informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating patients; 2. Complicated with cardio-cerebrovascular, liver, kidney, hematopoietic system and other serious primary diseases or serious diseases that seriously affect their survival; 3. Patients who have received antibiotics or probiotics within the past 1 month; 4. Have a known bacterial, fungal or viral infection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional analysis of immune cells; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life;Safety evaluation; | — |
Countries
China
Contacts
Public ContactYao Yandan
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Outcome results
None listed